01/28/2026
We’re excited to announce that Anirban Maitra, MD has been appointed the new director of Perlmutter Cancer Center at NYU Langone.
A pre-eminent physician-scientist whose work has widely influenced the field of pancreatic cancer research, Dr. Maitra joined NYU Langone in August 2025 as co-director of our Gastrointestinal (GI) Cancer Center, which brings together the collective expertise of our GI cancer experts to deliver care for patients with GI cancer or precancerous conditions. Prior to joining NYU Langone, he served as the inaugural scientific director of the Pancreatic Cancer Research Center at MD Anderson Cancer Center, where his work focused on early detection and biomarker development, two key avenues for effective cancer treatments.
“Dr. Maitra is a proven leader in oncology, and his experience guiding integrated, multidisciplinary teams makes him an outstanding choice to direct Perlmutter Cancer Center,” says Alec C. Kimmelman, MD, PhD, Dean of NYU Grossman School of Medicine and CEO of NYU Langone Health. “He brings a strong record of clinical and scientific achievement, a deep commitment to advancing cancer research, and the vision needed to help drive Perlmutter Cancer Center’s continued growth and impact on patients and families.”
“I am both humbled and excited to accept this opportunity to lead the Perlmutter Cancer Center,” Dr. Maitra says. “The integrated nature of this institution gives us so many opportunities to develop our understanding and agility to more rapidly develop new cancer therapies.”
Learn more about Dr. Maitra: https://bit.ly/4rl4BwR